Enanta Pharmaceuticals (ENTA) Current Assets (2016 - 2025)
Historic Current Assets for Enanta Pharmaceuticals (ENTA) over the last 14 years, with Q3 2025 value amounting to $204.3 million.
- Enanta Pharmaceuticals' Current Assets fell 3185.44% to $204.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $204.3 million, marking a year-over-year decrease of 3185.44%. This contributed to the annual value of $204.3 million for FY2025, which is 3185.44% down from last year.
- Latest data reveals that Enanta Pharmaceuticals reported Current Assets of $204.3 million as of Q3 2025, which was down 3185.44% from $222.7 million recorded in Q2 2025.
- In the past 5 years, Enanta Pharmaceuticals' Current Assets ranged from a high of $448.5 million in Q2 2023 and a low of $204.3 million during Q3 2025
- Over the past 5 years, Enanta Pharmaceuticals' median Current Assets value was $313.0 million (recorded in 2022), while the average stood at $318.6 million.
- As far as peak fluctuations go, Enanta Pharmaceuticals' Current Assets soared by 4326.35% in 2023, and later tumbled by 3609.67% in 2024.
- Enanta Pharmaceuticals' Current Assets (Quarter) stood at $327.0 million in 2021, then dropped by 13.23% to $283.7 million in 2022, then skyrocketed by 37.57% to $390.3 million in 2023, then crashed by 31.3% to $268.1 million in 2024, then decreased by 23.8% to $204.3 million in 2025.
- Its Current Assets was $204.3 million in Q3 2025, compared to $222.7 million in Q2 2025 and $242.9 million in Q1 2025.